What Buyers Actually Diligence in a Behavioral Health Deal

Most sellers assume diligence is about the financials. In behavioral health, the financials are usually the least surprising part. What reprices a deal — or kills it — is almost always something clinical, regulatory, or structural that nobody surfaced before the letter of intent.

Here is what a serious buyer actually works through, and what each one does to your price.

1. Revenue quality, not revenue size

Buyers do not underwrite the revenue on your P&L. They underwrite the revenue they believe survives the transition. That means payer mix, rate sustainability, authorization practices, and whether the documentation behind the billing holds up when someone competent reads a sample of charts.

Concentration is the usual problem: one payer, one referral source, or one contract that produces most of the census. Diversified commercial, Medicaid, and managed care revenue is worth more — provided the rates survive scrutiny.

2. Census and utilization trends

Buyers look at twelve to twenty-four months, not the last quarter. A facility with flat but stable utilization and a defensible referral pipeline is easier to underwrite than one with a spike in the trailing six months that nobody can explain.

3. Licensure and licensed capacity

What your license actually permits, whether the facility as operated matches the license, how hard that license is to obtain in your state, and what the transfer or change-of-ownership process looks like. Licensed capacity in a state with a restrictive licensing environment is one of the most valuable things a behavioral health owner holds.

4. Compliance and clinical documentation

Documentation practices, incident history, staffing ratios against licensure requirements, and anything a regulator would find on a return visit. Buyers diligence this hard because the liability transfers with the business. Issues found late are expensive; the same issues found early are cheap to fix.

5. Staffing and clinical leadership

In this sector the deal is the team. Retention of clinical leadership, turnover among licensed staff, and whether the program depends on one clinician's personal referral relationships are the most common reasons a deal gets repriced after LOI.

6. Real estate and occupancy cost

Whether the property is owned, leased, or held by a related party — and on what terms. Buyers restate related-party rent to a market lease, which flows directly into the adjusted EBITDA they are underwriting. If the building is leased, the renewal terms and who else controls the property matter as much as the rent.

7. Seller readiness

Whether the owner is genuinely prepared to transact or testing the market. This one is not written down anywhere, but it changes everything: how much diligence the buyer funds, how the LOI is drafted, and how hard they push on price.

The practical takeaway

Every item on this list is easier to fix before you go to market than to defend during diligence. The work of preparing a facility for sale is mostly the work of removing surprises — and it is the same work that raises the number in the first place.

If you want to know how your facility would hold up under this review, start with valuation and exit planning. If you are on the buy side and want opportunities screened against these criteria before they reach you, see buy-side representation.

If you operate detox or residential beds, our page on detox and residential transactions covers what buyers underwrite in that asset class. For outpatient programs, the PHP and IOP page goes deeper on payer mix, authorizations, and staffing ratios.